Press release
Why Synergy (NASDAQ: SNYR) Could Hit $7 Sooner Than Expected - Beverage Rollout Ignites 2026 Growth Acceleration
Synergy CHC Corp. (NASDAQ: SNYR) is drawing renewed attention after Roth Capital Partners reaffirmed its Buy rating and issued a $7 price target, citing strong fundamentals, a growing product portfolio, and a new phase of revenue acceleration driven by the company's expanding functional beverage business.Along with Synergy CHC Corp. (NASDAQ: SNYR), see SmallCap Stocks to Watch Now: Black Titan (NASDAQ: BTTC), PetMed Express Inc (NASDAQ: PETS), Mawson Infrastructure (NASDAQ: MIGI) and Velo3D Inc (NASDAQ: VELO), all active in intraday trading sessions.
Roth noted that while third-quarter 2025 results came in below expectations due to temporary cash constraints, the company's recent $4 million equity raise has fortified its balance sheet and positioned Synergy for substantial growth in 2026. Analysts highlighted that the company's infrastructure investments and expanded retail footprint-including the rollout of FOCUSfactor Registered Focus + Energy into 1,600+ EG America locations-are setting the stage for a sharp sales ramp through existing distribution partners such as Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), CVS (NYSE: CVS), and Walgreens (NASDAQ: WBA).
Roth Capital projects revenues could rise from $35.4 million in 2025 to approximately $55 million in 2026, largely driven by the beverage division's integration into Synergy's well-established retail channels. Gross margins remain strong at 70%, with profitability supported by 10 consecutive positive quarters.
The firm's $7 target is based on a 6.2x EV/EBITDA multiple of projected 2027 results, reflecting the potential for significant shareholder value as Synergy leverages its 25-year FOCUSfactor Registered brand legacy already established as a household name throughout the US, Canada, UK, etc. has expanded internationally into the UAE, Turkey as well as other south and central American countries.
The firm's $7 target is based on a 6.2x EV/EBITDA multiple of projected 2027 results, underscoring the potential for substantial shareholder value as Synergy builds on its 25-year FOCUSfactor Registered brand legacy-already a household name across the U.S., Canada, and the U.K.-and expands internationally into the UAE, Turkey, and multiple markets throughout South and Central America.
With capital in place, new retail partnerships, and a rising consumer shift toward brain health and functional beverages, analysts believe SNYR is positioned for a breakout year in 2026 as sales momentum accelerates across all channels. See Complete Roth Capital Report. [https://thestreetreports.com/wp-content/uploads/2025/11/SNYR_-3Q-Comes-Up-Short_-Recent-Cash-Raise-Sets-Up-Growth-Ac.pdf]
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=why-synergy-nasdaq-snyr-could-hit-7-sooner-than-expected-beverage-rollout-ignites-2026-growth-acceleration]
Country: United States
Website: http://www.thestreetreports.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why Synergy (NASDAQ: SNYR) Could Hit $7 Sooner Than Expected - Beverage Rollout Ignites 2026 Growth Acceleration here
News-ID: 4312294 • Views: …
More Releases from ABNewswire
UK Taxpayers Turn to the Best App for Filing Taxes as Digital Submissions Surge …
As HMRC continues to support online interactions, app-based filing is becoming standard practice across the UK. The shift reflects a wider move toward self-service financial tools that prioritise usability, transparency, and speed. Pie's product strategy centres on making tax approachable and human, reinforcing its proposition: It's your money. Claim it.
LONDON, United Kingdom - February 23, 2026 - UK taxpayers are increasingly relying on mobile apps to manage and submit their…
How to Find Reputable Gold Dealers and Avoid Scams in 2026
Image: https://www.abnewswire.com/upload/2026/02/47e5b4ef7e33f72e2f9ac00f352f35cf.jpg
Investing in physical gold is a time-honored strategy for wealth preservation and hedging against economic uncertainty. However, the integrity of your investment depends entirely on the trustworthiness of your dealer. In 2026, the digital landscape is fraught with both industry leaders and sophisticated scammers.
To protect your capital and ensure the authenticity of your gold, you must know how to find reputable gold dealers [https://sdbullion.com/gold] and identify the red flags…
Most Personality Tests Were Built for Extroverts. Introvert Strength Quizzes Wer …
A new platform challenges how quiet thinkers have been measured and misunderstood for decades.
In a world that rewards speed, visibility, and constant expression, introverts have quietly adapted. They've learned to participate without dominating. To contribute without a spotlight. To think before speaking.
But what if the very tools used to "understand" personality were never designed to measure introverted strength in the first place?
Introvert Strength Quizzes launches with a bold premise:
Introverts have…
Biliary Tract Cancers Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead …
DelveInsight's "Bladder Cancer Pipeline Insight 2026" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bladder Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in…
More Releases for NASDAQ:
Blasting Off with Space Sector Companies Including: Ascent Solar Technologies: N …
With the Artemis II Manned Moon Mission Set to Launch Could $ASTI be on the Same Rocket Ride Trajectory as $ASTS and $LUNR?
Image: https://www.globalnewslines.com/uploads/2026/02/13b5a8ac7a0c22438ac498119e1b3551.jpg
$ASTI is Positioned to Serve the $1 Trillion Global Space Economy Projected by 2040 .
Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio. ASTI is a leading provider of…
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release.
Financials Mischaracterized, Says Peraso
Peraso rebuffed Mobix's…
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its…
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an…
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after…
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders…
